Phase II Trial of a Novel Paclitaxel Schedule As Single-Agent, First-Line Therapy for HER-2/neu-Negative Metastatic Breast Cancer: A Community-Based Study
-
Published:2006-11-01
Issue:6
Volume:2
Page:268-273
-
ISSN:1554-7477
-
Container-title:Journal of Oncology Practice
-
language:en
-
Short-container-title:Journal of Oncology Practice
Author:
Loesch D.,Robert N.,Jones S.,Elkordy M.,Ilegbodu D.,Asmar L.
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Health Policy,Oncology(nursing),Oncology